Clinical trial

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

NCT01691482

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Albuterol/salbutamol Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ipratropium Normalized identity: ipratropiumView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-07-23

PhasePHASE4

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

Albuterol/salbutamolDRUG

IpratropiumDRUG · verified · RxNorm: ipratropium

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

ManchesterUnited Kingdom1 SpartanburgSouth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01691482 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.